SPROUT Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SPROUT, and what generic alternatives to SPROUT drugs are available?
SPROUT has one approved drug.
There is one US patent protecting SPROUT drugs.
There are thirty-nine patent family members on SPROUT drugs in twenty-nine countries.
Drugs and US Patents for SPROUT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | RX | Yes | Yes | 7,151,103 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SPROUT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | 9,468,639 | ⤷ Try a Trial |
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | 7,420,057 | ⤷ Try a Trial |
Sprout Pharms | ADDYI | flibanserin | TABLET;ORAL | 022526-001 | Aug 18, 2015 | 8,227,471 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SPROUT Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2012067134 | ⤷ Try a Trial |
Poland | 367358 | ⤷ Try a Trial |
Denmark | 1446122 | ⤷ Try a Trial |
European Patent Office | 1674102 | ⤷ Try a Trial |
Argentina | 077480 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.